Navigation Links
Ventria Hires Director of Global Regulatory Affairs
Date:11/27/2007

JUNCTION CITY, Kan., Nov. 27 /PRNewswire/ -- Ventria Bioscience announced today that Quentin B. Kubicek, Ph.D. would be joining the company as Director, Global Regulatory Affairs.

Dr. Kubicek joins Ventria with more than 20 years experience in regulatory affairs and policy development related to plant biotechnology. Prior to joining Ventria, Quentin worked with InterAmerican Institute for Cooperation on Agriculture (IICA) where he developed regulatory policies on behalf of several Latin American and Caribbean governments for products derived from biotechnology. Quentin has also held regulatory positions with Dupont Nutrition and Health and the United States Department of Agriculture. He received his Ph.D. in Molecular Biology from Texas A&M University.

"Quentin's proven leadership, scientific credentials and his experience working in regulatory affairs and policy development will help accelerate Ventria's growth as we achieve our vision for affordable healthcare solutions," said Scott Deeter, President and CEO, Ventria Bioscience. "Quentin will lead Ventria's Global Regulatory Affairs Group," he said.

"I am excited to be joining the Ventria team at a time of rapid growth so that I can utilize my experience to help Ventria achieve its vision of delivering affordable health care products to the global community," said Kubicek.

A recent child health study showed that Ventria's Lactiva and Lysomin helped reduce the duration of diarrhea in children by 30 percent when added to rehydration solutions. Childhood diarrhea is the second leading killer of children, claiming 2 million lives annually according to the World Health Organization.

For more information, see our website at Ventria Bioscience http://www.ventria.com

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.


'/>"/>
SOURCE Ventria Bioscience
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ventrias Child Health Product Recognized for Its Promise
2. Pioneer Surgical Technology Hires Vice President of New Business Development
3. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
4. LehmanMillet Continues Expansion with Strategic Hires
5. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
6. Staffing Agency Hires Local Television News Team, Launches Broadband Network for Nurses
7. Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model
8. Flagship Global Health Hires Health Care Veteran Larsen to Head Marketing and Sales
9. Pioneer Surgical Technology Hires New Spinal Franchise Manager
10. ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support
11. FBR Capital Markets Hires Senior Healthcare Analyst
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... Prater Eye Center becomes the first in the area to offer AngioPlex™ Optical ... signs of retinal disease, such as macular degeneration, diabetic retinopathy, and other vascular ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... Many individuals ... of protein for a multitude of reasons. IsoPasta by Isolator Fitness has delved ... it once more, but without the high-carb repercussions. IsoPasta has 30 grams of ...
(Date:2/13/2016)... ... February 13, 2016 , ... Christie Medical Holdings, ... gift of a VeinViewer® Vision vein finder for the nursing school ... an IV and draw blood, combining technology with traditional technique. , “VeinViewer is ...
(Date:2/12/2016)... CA (PRWEB) , ... February 12, 2016 , ... According ... hernia surgeries are beginning to account for a significant portion of hernia repairs throughout ... Towfigh of the Beverly Hills Hernia Center notes that this trend has not only ...
(Date:2/12/2016)... FL (PRWEB) , ... February 12, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted over 250 members of South Florida’s philanthropic community at its 10th ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)...  Sequent Medical, Inc. announced today that it has ... safety and effectiveness of the WEB™ Aneurysm Embolization System ... Prof Laurent Spelle , MD, Head of Neuroradiology ... and Principal Investigator of the CLARYS study, ... and Germany.  Although patients with ruptured aneurysms have ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... WILMINGTON, North Carolina , 12 februari ... Laboratories, Inc. (AAI/CML), een toonaangevende leverancier van ... farmaceutische en biotechnologische industrieën, kondigt vandaag een ... en mogelijkheden op haar locatie in ... in vraag heeft geleid tot meerdere recente ...
Breaking Medicine Technology: